Metalβorganic framework nanovaccines for systemic tumour regression
Nature Biomedical Engineering, Published online: 06 October 2026; doi:10.1038/s41551-026-01786-5
A nanoscale metalβorganic framework (MOF)-based cancer vaccine platform enables coordinated antigen presentation and innate immune activation, resulting in tumour regression, immune memory and protection against metastasis.